Files

Download

Download Full Text (292 KB)

Description

Purpose:

  • Identify medications prescribed to manage NAS due to opioids and /or amphetamines.
  • Evaluate average daily medication wean rates.
  • Assess length of stay (LOS) and length of treatment (LOT)

Publication Date

12-2018

Keywords

Neonatal Abstinence Syndrome, Retrospective patient review, NAS evaluation, Morphine, Clonidine

Disciplines

Medicinal and Pharmaceutical Chemistry

Comments

Poster presented at The American Society of Health-System Pharmacists Midyear Clinical Meeting, December 5, 2018; Anaheim, CA

Evaluation of Neonatal Abstinence Syndrome Management and Prescribing Patterns

Share

COinS